2020 cohort company Astarte Medical’s chief medical officer Dr. William Hay Jr. discusses how healthcare provider organizations can turn the tide on pediatric healthcare costs – and what new digital tools and protocols may need to be in place to improve outcomes for vulnerable pediatric patients. Read more here.
2022 cohort company Acorai, a start-up medical device manufacturer from Sweden, announced its selection for a €2.3m grant with a follow-on €10m investment offer from the European Innovation Council (EIC). Only a handful of companies who apply for the EIC accelerator are successful, and Acorai was among the top applicants who received the maximum funding Amount. Read more here.
2023 cohort company SmartCardia has announced that Dr. Jag Singh joined the company as their new Principal Medical Advisor. SmartCardia is a leading provider of an integrated cloud platform and patch for cardiac and remote patient monitoring. Read more here.
2020 cohort company Zeto, an innovative EEG brain monitoring company, has announced its inaugural participation at the Neuroscience 2023 conference hosted by the Society for Neuroscience and has reaffirmed its commitment to increasing accessibility to brain monitoring by sponsoring up to three EEG clinical trials in 2024. These trials aim to support advanced clinical research and bring innovative applications closer to full real-world implementation. Read more here.
2022 cohort company iCardio.ai has announced it has joined Butterfly Garden, a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software. Under the agreement, iCardio.ai plans to develop and deploy its suite of cardiac ultrasound AI tools for use with Butterfly's single-probe, whole-body handheld ultrasound system, subject to applicable approvals and authorizations. Read more here.
2018 cohort company Lapovations announced a national pricing agreement with CommonSpirit Health, one of the United States’ largest nonprofit healthcare systems. This agreement establishes a national pricing framework and paves the way for widespread adoption of AbGrab, an innovative device designed to offer a more reliable and less invasive method for lifting the abdominal wall during laparoscopic surgeries. Read more here.
Results from an ongoing prospective clinical study conducted by Scripps Clinic indicate that 2023 cohort company MindMics' non-invasive infrasonic hemodynography (IH) technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles. Read more here.